COMMUNIQUÉS West-GlobeNewswire

Florida Hospital Nicholson Center Announces New Mobile Broadcast Solution, the B-Hive

12/12/2017 - 15:02

CELEBRATION, Fla., Dec. 12, 2017 (GLOBE NEWSWIRE) -- The Florida Hospital Nicholson Center , one of the leading robotic training centers in the country, today announces the launch of the B-Hive , an adaptable mobile [...]

AXIM Biotech Announces Successful Completion of Pre-IND Meeting with FDA on Comparable Product to Marinol; Green Light from FDA for IND Submission

12/12/2017 - 15:00

NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), a world leader in cannabinoid research and development, announced today that it has successfully completed a pre-investigational New [...]

American Gene Technologies Receives U.S. Patent on Novel Immuno-Oncology Methods of Treating Cancer through Activation of Gamma Delta T Cells

12/12/2017 - 15:00

ROCKVILLE, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced the issuance of U.S. Patent No: 9,834,790 dated December 5 [...]

Acer Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock

12/12/2017 - 15:00

NEWTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]

CV Sciences, Inc. to Exhibit at the 25th Annual World Congress on Anti-Aging Medicine in Las Vegas, NV - December 14-16th, 2017

12/12/2017 - 14:45

LAS VEGAS, Dec. 12, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting at the 25th Annual World Congress on Anti-Aging [...]

TPP Healthcare to Offer 1:1 Meeting Space during JP Morgan and Biotech Showcase Healthcare Week in San Francisco – January 8-10, 2018

12/12/2017 - 14:30

NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- TPP Healthcare , a strategic advisory firm specializing in cross-border transactions between US, Europe and China’s healthcare companies, in partnership with B. Riley FBR , [...]

Soleno Therapeutics Announces $15 Million Private Placement

12/12/2017 - 14:30

Financing to Support Planned Phase III Clinical Program for DCCR in Prader-Willi Syndrome REDWOOD CITY, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO ), a clinical-stage [...]

UroGen Pharma Expands Clinical Development Leadership Team

12/12/2017 - 14:30

Mark Schoenberg, M.D., Named Chief Medical Officer Elyse Seltzer, M.D., Appointed Senior Vice President of Clinical Development RA'ANANA, Israel and NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ [...]

Rockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic® in Peru

12/12/2017 - 14:30

- Estimated Market Launch 2 nd -half 2018 Provides Access to 13,000 Dialysis Patients - WIXOM, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI ), announced today that it has signed an [...]

Portola Pharmaceuticals Provides Update on European Marketing Authorization Application for Betrixaban

12/12/2017 - 14:30

South San Francisco, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]

Roy Davis Joins Liquid Biopsy Company Clinical Genomics Board of Directors

12/12/2017 - 14:30

BRIDGEWATER, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Roy Davis as Senior Advisor and [...]

Onconova Presents Data on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2017 Meeting

12/12/2017 - 14:30

Oral rigosertib as a single agent demonstrates activity in a Phase 2 trial for lower-risk MDS 32% of 62 evaluable patients, and 44% of patients receiving optimal dosing, achieved transfusion independence New data on the [...]

assessURhealth, LLC Partners with athenahealth’s ‘More Disruption Please’ Program to Enhance Access to Mental and Behavioral Health Screening Tools

12/12/2017 - 14:01

Tampa, FL, Dec. 12, 2017 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a provider of mental and behavioral health screening software, today announced a partnership with athenahealth , Inc. through athenahealth’s ‘ More [...]

scPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

12/12/2017 - 14:00

BURLINGTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused [...]

Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer

12/12/2017 - 14:00

Prominent cancer centers expand portfolio of patient-centric treatment solutions with Xoft’s innovative, painless, scar-free solution NASHUA, N.H., Dec. 12, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD ), a global [...]

New York eHealth Collaborative Selects HealthEC to Provide MIPS Reporting through its Qualified Clinical Data Registry Services

12/12/2017 - 14:00

PISCATAWAY, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- HealthEC today announced that it has been selected by the New York eHealth Collaborative (NYeC) to customize its Merit-based Incentive Payment System (MIPS) reporting [...]

VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

12/12/2017 - 14:00

CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV ) (TSX: VBV ) (VBI) today announced that Jeff Baxter, President and CEO, will present at the BMO Capital Markets Prescriptions for [...]

Aduro Biotech Provides Update on CRS-207 Programs

12/12/2017 - 14:00

BERKELEY, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today provided an update on its clinical development [...]

Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15

12/12/2017 - 14:00

NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report [...]